The global Atherectomy Devices market will reach US$ 1,546.1 Mn by 2026 – says PMR, a well-known name in market research.
The current scenario is such that the North American market is projected to claim a massive share of the atherectomy devices market in the years to come due to the favorable reimbursement environment and the growing demand for minimally invasive procedures. This scenario is, by all means, favoring the Atherectomy Devices market growth. The forecast period (2022-2026) will see North America scale greater heights in the Atherectomy Devices market. This is basically because cardiovascular diseases are the biggest global cause of mortality, accounting for nearly 18.6 million deaths in the United States in 2019 alone. This factor puts pressure on the country’s healthcare system, hence, the demand for atherectomy devices is projected to increase in the near future.
Request For Free Sample Report of Atherectomy Devices Market @ https://www.persistencemarketresearch.com/samples/3516
Europe will maintain its second-place ranking and grow at a promising rate in the coming years. Furthermore, the growing elderly population, and increased contributions from countries like India, China, and Japan, are also expected to ensure the market’s robust expansion during the forecast period.
The COVID-19 pandemic did disrupt the entire economy in wake of the healthcare personnel shifting their focus on combating Covid-19. However, the scenario has improved after September 2021.
Competitive Landscape
The Atherectomy Devices industry is moderately competitive and highly consolidated due to the presence of several large players. Key players in the market are focusing on mergers and acquisitions as the industry is in the growth phase. Companies are making strategic decisions regarding organic as well as inorganic expansion in order to expand their product portfolios and grow their market share.
Royal Philips launched peripheral and coronary artery applications, including the Nexcimer laser system, in North America in November 2021. The Nexcimer laser system can be used for peripheral and coronary atherectomy as well as lead extraction procedures.
Cardiovascular Systems, Inc. received CE Mark in January 2021 for its Diamondback 360 Coronary Orbital Atherectomy System (OAS), which combines differential sanding and pulsatile forces to treat all calcium modalities, including nodular, eccentric (irregular), and concentric calcium modalities (ring-shaped).
For critical insights on this market, request for customization here@ https://www.persistencemarketresearch.com/request-customization/3516
Atherectomy Devices Market Categorization
Atherectomy Devices Market by Indication
- Coronary Artery Diseases
- Peripheral Artery Diseases
Atherectomy DevicesMarket by Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
Want More Insights?
PMR has presented a comprehensive report based on Atherectomy Devices market as per Device Type (rotational atherectomy devices, directional atherectomy devices, orbital atherectomy devices and laser ablation atherectomy devices.), Indication (coronary artery diseases and peripheral artery diseases) based on seven regions.
Buy Full Report Now and Get Upto 20% Discount @ https://www.persistencemarketresearch.com/checkout/3516
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353